[1]
Glaser, D.A., Hebert, A.A., Nast, A., Werschler, W.P., Shideler, S., Green, L., Mamelok, R.D., Drew, J., Quiring, J. and Pariser, D.M. 2018. Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S40. DOI:https://doi.org/10.25251/skin.2.supp.40.